Correlation of the Virological Response to Short-Term Maraviroc Monotherapy with Standard and Deep-Sequencing-Based Genotypic Tropism Prediction Methods

Genotypic tropism testing methods are emerging as the first step before prescription of the CCR5 antagonist maraviroc (MVC) to HIV-infected patients in Europe. Studies validating genotypic tests have included other active drugs that could have potentially convoluted the effects of MVC. The maraviroc...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gonzalez-Serna, A., McGovern, R. A., Harrigan, P. R., Vidal, F., Poon, A. F. Y., Ferrando-Martinez, S., Abad, M. A., Genebat, M., Leal, M., Ruiz-Mateos, E.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology 2012
Materias:
Antiviral Agents
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3294910/
https://ncbi.nlm.nih.gov/pubmed/22143533
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.05857-11
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares